VON MOLTKE LISA (See Remarks) sold 2.9% of their position (977.00 shares) of SERES THERAPEUTICS, INC. on the open market
Open‑market sale worth $528.26 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/19/2024ACC: 0000950170-24-128626
Officer· See Remarks
Since Apr 2020
-977.00
Net shares
Net seller
$528.26
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.97K acquired · 3.95K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.97K
Price / share
—
Trade value
—
% of position
9.8%
11/15/2024
30.42K→33.39K
Common Stock
Direct
Shares
−977.00
Price / share
$0.54
Trade value
$528.26
% of position
2.9%
11/18/2024
33.39K→32.41K
Total
Net shares
+1.99K
Net value
-$528.26
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/15/2024 | M · Option Exercise | +2.97K | — | — | 9.8% | 30.42K | 33.39K |
| Common Stock Direct | 11/18/2024 | S · Sale | −977.00 | $0.54 | $528.26 | 2.9% | 33.39K | 32.41K |
| Total | +1.99K | -$528.26 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
2.97K shares
Shares
−2.97K
Strike price
Held after
26.72K
Exercisable
—
11/15/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock2.97K shares | 11/15/2024 | M · Option Exercise | −2.97K | — | 26.72K |